preclinical and clinical evaluation of the effect of siddha classical drug KANAI KIRUTHAM(oral administration)in the management of WHEEZING ASSOCIATED LOWER RESPIRATORY TRACT INFECTIO
Phase 2
Completed
- Conditions
- Health Condition 1: J459- Other and unspecified asthma
- Registration Number
- CTRI/2022/02/039924
- Lead Sponsor
- Dr J Jayamani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1.Cough (productive or dry )
2.Difficulty in breathing (Respiratory cause only)
3.Wheezing
4.Fever
5. Allergic asthma
Exclusion Criteria
1.Children above 13years
2.Children below 3 years
3.Difficulty in breathing other than the respiratory cause
4.Congestive cardiac failure
5.ARDS
6.Silent chest
7.Emergency case
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in clinical symptoms like cough, difficulty in breathing, wheezing, low grade fever, mild head ache.Timepoint: Reduction in clinical symptoms like cough, difficulty in breathing, wheezing, low grade fever, mild head ache.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI